Following the release of the appraisal consultation document (ACD), we have suspended this appraisal. The company (Merck Sharp & Dohme) requested that NICE suspend this appraisal because it is considering its commercial arrangement for this product. Therefore, the basis for the decision making is likely to change and the appraisal committee meeting (previously scheduled for 8 August 2018) will be rescheduled.